Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 45 results for "ranjit kapadia"

Lupin: Earnings upgrades likely after stellar Q1
Sify

Experts bullish on Lupin after stellar Q1 performance

A Speaking to CNBC-TV18 post the result, Ranjit Kapadia of Centrum Broking expects Lupin to report a good performance on domestic front as well just like its peers Ranbaxy and Pfizer. He is highly bullish on the stocks backed by its strong Q1 ... Moneycontrol.com, 1 month ago
Lupin: Earnings upgrades likely after stellar Q1 Smart Investor, 1 month ago

Sell Ranbaxy; Sun Pharma may test Rs 780: Ranjit Kapadia

Ranjit Kapadia of Centrum Broking is of the view that Sun Pharmaceutical Industries may test Rs 780.
 Money Control2 months ago Sun Pharma to firm up steps to boost Ranbaxy drug sales  Economic Times1 week ago Sun Pharma buys US drug maker  Smart Investor2 months ago Sun Pharma buys US-based injectable firm Pharmalucence  DNA India2 months ago
[x]  

Lupin in deal to develop product portfolio for Merck

Pharma major Lupin said it has entered into a long-term strategic partnership with Merck Serono, the biopharmaceutical division of Merck, for implementing the Germany-based company's general medicines portfolio expansion initiative in emerging markets. The ...
 DNA6 hours ago

2G Case: Justice Dattu seeks advice; KK Venugopal refuses citing conflict of interest, JethmalaniNew

The hearing in the 2G case in the Supreme Court took an interesting turn yesterday. All set to take over as the next Chief Justice of India (CJI), Justice Dattu initially sought Senior Advocate KK Venugopal's advice on whether the affidavit ...
 Bar & Bench15 hours ago
DNA India

Sun tanks 6% as Halol unit comes under cloud

Shares of Sun Pharmaceutical Industries dropped over 4% on Thursday on unconfirmed reports that the US Food and Drug Administration (FDA) made a surprise inspection at its manufacturing facility at Halol in Gujarat. The scrip opened at Rs 853 on ...
 DNA India5 days ago
DNA India

IPCA Laboratories : Pharma cos may be hit by new price controls

Mumbai : The National Pharmaceutical Pricing Authority (NPPA) has fixed prices of ten combination drugs under Drugs Prices Control Order (DPCO), 2013. This is a part of a recent move taken by the NPPA to fix or revise prices in respect of 56 ...
 4 Traders2 weeks ago Fresh drug price control rule may hit Indian pharmaceutical companies  DNA India2 weeks ago Pharma companies shrug off price control, grow domestic business  DNA India3 weeks ago NPPA moves to bring cancer drugs under price control regime  4 Traders1 month ago

RANBAXY LABORATORIES : may face another hefty fine in the US of Rs 240 crore

NEW DELHI : Ranbaxy Laboratories may have to pay another hefty fine in the United States of close to Rs 240 crore , this time imposed by the State of Texas , people familiar with the matter told ET. The company has been in negotiation with the US ...
 4 Traders2 weeks ago Ranbaxy Laboratories may face another hefty fine in the US of Rs 240 crore  Economic Times3 weeks ago Ranbaxy overcharged Texas for drugs under its public-funded Medicaid programme: US Report  Economic Times3 weeks ago US slaps Rs 240-crore fine on Ranbaxy Laboratories over for fraud in its Medicaid programme  Economic Times3 weeks ago

Cipla expects growing tender biz not to hurt margins

Pharma major Cipla has said its proportion of low-margin tender business through government bids to the export sales may increase from less than 10% at present, but expects it will not have any adverse impact on its margins. Rajesh Garg, global ...
 DNA India3 weeks ago Cipla expects growing tender business not to hurt margins  DNA India2 weeks ago
Business Standard India

Sanofi India: Relief a few quarters away

Sanofi India's recent tie-up with Emcure Pharmaceuticals to jointly market their portfolio of anti-cancer drugs is positive. Although the stock has gained about four% since the tie-up news came, it will be a couple of quarters before the overhang of ...
 Business Standard India3 weeks ago

CBI may book Marans in Aircel case

The CBI is likely to file a charge sheet against former telecom minister Dayanidhi Maran and his brother Kalanidhi, the promoters of Sun Group, for alleged coercion in the takeover of Aircel by Malaysian company Maxis as Attorney General Mukul Rohatgi said ...
 Deccan Herald1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less